AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$1.18M
(+0.03%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
87
Reduced
63
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Exact Sciences
EXAS
|
$59.2M |
| 3 |
Sanofi
SNY
|
$53M |
| 4 |
Keurig Dr Pepper
KDP
|
$49.6M |
| 5 |
GSK
GSK
|
$39.9M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
DexCom
DXCM
$31.6B
| – | – |
-8,328
| Closed | -$944K |
|
277
Elanco Animal Health
ELAN
$9.16B
| – | – |
-14,811
| Closed | -$214K |
|
278
Elicio Therapeutics
ELTX
$188M
| – | – |
-100,000
| Closed | -$411K |
|
|
279
Exact Sciences
EXAS
$10.2B
| – | – |
-1,400,086
| Closed | -$59.2M |
|
280
First Watch Restaurant Group
FWRG
$1.13B
| – | – |
-185,000
| Closed | -$3.25M |
|
281
Genelux
GNLX
$127M
| – | – |
-900,000
| Closed | -$1.76M |
|
282
Genprex
GNPX
$7.68M
| – | – |
-218,000
| Closed | -$411K |
|
283
GeoVax Labs
GOVX
$17.7M
| – | – |
-80,000
| Closed | -$255K |
|
284
GRI Bio
GRI
$4.18M
| – | – |
-2,953
| Closed | -$96.4K |
|
285
Goodyear
GT
$2.43B
| – | – |
-10,049
| Closed | -$114K |
|
286
Hudbay
HBM
$5.03B
| – | – |
-10,770
| Closed | -$97.5K |
|
|
HEPA
287
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
-10,320
| Closed | -$526K |
|
288
Hoth Therapeutics
HOTH
$17.6M
| – | – |
-213,000
| Closed | -$194K |
|
289
Helius Medical Technologies
HSDT
$6.4M
| – | – |
-173
| Closed | -$127K |
|
290
IO Biotech
IOBT
$128M
| – | – |
-1,545,000
| Closed | -$1.81M |
|
291
iPower
IPW
$16.6M
| – | – |
-1,463,000
| Closed | -$3.04M |
|
292
Kenvue
KVUE
$35.7B
| – | – |
-1,588,358
| Closed | -$28.9M |
|
293
Lexaria Bioscience
LEXX
$20.1M
| – | – |
-1,020,000
| Closed | -$2.84M |
|
294
M&T Bank
MTB
$31.2B
| – | – |
-1,512
| Closed | -$229K |
|
295
NLS Pharmaceutics
NLSP
$9.62M
| – | – |
-57,775
| Closed | -$501K |
|
296
NeuroSense Therapeutics
NRSN
$29.6M
| – | – |
-1,584,000
| Closed | -$1.77M |
|
297
On Holding
ONON
$14.9B
| – | – |
-12,811
| Closed | -$497K |
|
298
PainReform
PRFX
$2.86M
| – | – |
-11,500
| Closed | -$132K |
|
|
ATON
299
AlphaTON Capital Corp. Common Stock
ATON
$11.6M
| – | – |
-75,089
| Closed | -$319K |
|
|
PTN
300
DELISTED
Palatin Technologies
PTN
| – | – |
-1,678,101
| Closed | -$3.27M |
|